Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honghua dripping pill Phase III trial in stable exertional angina (blood stasis pattern)
CTR20132966Phase 3Completed
- Sponsor
- Shanxi Deyuantang Pharmaceutical
- Start
- Mar 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Honghua dripping pill in angina pectoris, coronary arteriosclerosis, sponsored by Shanxi Deyuantang Pharmaceutical. Started Mar 2015; status: completed.
02
Drugs
Honghua dripping pill
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20132966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132966.